Literature DB >> 3703407

Fetal outcome with oligohydramnios in the second trimester.

L J Mercer, L G Brown.   

Abstract

Thirty-four cases of oligohydramnios in the second trimester were diagnosed by ultrasonography. Nine of these pregnancies were associated with fetal anomalies including Potter syndrome (three), atrioventricular dissociation (two), congenital absence of thyroid (one), and multiple anomalies (three). There were ten unexplained stillbirths, one demise due to abruptio placentae, eight with perinatal morbidity after premature labor or abruptio placentae, and six with live-born term infants. Although oligohydramnios in the second trimester is associated with increased perinatal morbidity, this finding is not associated with a universally poor outcome.

Entities:  

Mesh:

Year:  1986        PMID: 3703407     DOI: 10.1097/00006250-198606000-00019

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

Review 1.  Current State of Fetal Intervention for Lower Urinary Tract Obstruction.

Authors:  Douglass B Clayton; John W Brock
Journal:  Curr Urol Rep       Date:  2018-02-22       Impact factor: 3.092

Review 2.  Definition, diagnosis and management of fetal lower urinary tract obstruction: consensus of the ERKNet CAKUT-Obstructive Uropathy Work Group.

Authors:  Valentina Capone; Nicola Persico; Alfredo Berrettini; Stèphane Decramer; Erika Adalgisa De Marco; Diego De Palma; Alessandra Familiari; Wout Feitz; Maria Herthelius; Vytis Kazlauskas; Max Liebau; Gianantonio Manzoni; Michal Maternik; Giovanni Mosiello; Joost Peter Schanstra; Johan Vande Walle; Elke Wühl; Elisa Ylinen; Aleksandra Zurowska; Franz Schaefer; Giovanni Montini
Journal:  Nat Rev Urol       Date:  2022-02-08       Impact factor: 16.430

3.  Heparin successfully improved an early onset intrauterine growth restriction accompanied by severe oligohydramnios.

Authors:  Hong-Nü Chu
Journal:  Int J Gen Med       Date:  2008-11-30

4.  Treating oligohydramnios with extract of Salvia miltiorrhiza: A randomized control trial.

Authors:  Hong-Nü Chu; Mei-Juan Shen
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.